Medicare Advantage参保者接受癌症手术时更少进入高质量医院
结果显示MA参保者在所有癌种中更少在高死亡率最低五分位医院手术,也更少绕过低质量医院,提示MA计划网络可能限制最优手术可及性。
要点
- MA参保者比TM参保者更少在高质量医院接受癌症手术。
- MA参保者更少绕过低质量医院去高质量医院手术。
- MA计划网络可能限制最优手术可及性。
核心结论
- MA参保者接受癌症手术时更少进入高质量医院,也更少绕过低质量医院,提示当前MA计划网络可能限制最优手术可及性。
主要发现
- MA参保比例从2016年32%升至2022年46%。
- MA参保者更可能来自社会弱势地区、合并症更多,且在所有癌种中更常在非教学医院手术。
- 食管切除术在高质量医院的比例:TM为21.7%(95%CI 20.7%-22.8%),MA为17.3%(95%CI 16.1%-18.5%)。
- 胰腺切除术在高质量医院的比例:TM为22.6%(95%CI 22.1%-23.2%),MA为16.2%(95%CI 15.6%-16.8%)。
- TM参保者在所有术式中更可能绕过低质量医院去高质量医院手术。
关键数值与推荐
- 高质量医院定义为经混合效应逻辑回归模型风险调整患者特征、可靠性调整病例量后,调整医院死亡率最低五分位的医院。
临床怎么用
- 普通外科医生应关注MA参保者癌症手术的医院选择,评估计划网络对高质量医院可及性的影响。
- 转诊时可考虑帮助MA参保者识别网络内高质量医院,减少因网络限制导致的不必要低质量医院手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Enrollment in Medicare Advantage (MA) accounts for more than half of Medicare beneficiaries. Despite this growth, its impact on access to high-quality cancer surgery remains unclear. OBJECTIVE: To evaluate the association between MA enrollment and receipt of surgery at high-quality hospitals among Medicare beneficiaries undergoing major cancer surgery. DESIGN, SETTING, AND PARTICIPANTS: This national retrospective cohort study uses Medicare Provider Analysis and Review (MedPAR) data from January 1, 2016, to November 30, 2022. The study included 567 770 Medicare beneficiaries undergoing elective surgery for esophageal, pancreatic, liver, gastric, bladder, colon, kidney, or prostate cancer at hospitals across the United States. Data analysis was performed from August 2024 to July 2025. EXPOSURE: Enrollment in Medicare Advantage plan. MAIN OUTCOMES AND MEASURES: The primary outcome was surgery at a high-quality hospital, defined by procedure-specific mortality, risk-adjusted for patient characteristics and reliability-adjusted for differences in case volume using mixed-effects logistic regression models. Adjusted hospital mortality was rank ordered and sorted into quintiles. High quality was defined as hospitals in the quintile with the lowest mortality rates. The secondary outcome was likelihood of bypassing the nearest hospital of lower quality to undergo surgery at a high-quality hospital. RESULTS: Among 567 770 beneficiaries undergoing surgery, 351 447 were enrolled in traditional Medicare (TM; 231 104 [65.8%] male, 120 343 [34.2%] female; mean [SD] age, 72.5 [8.0] years) and 216 323 in MA (138 554 [64.0%] male, 77 769 [36.0%] female; mean [SD] age, 72.7 [7.6] years). MA enrollment increased from 32% in 2016 to 46% in 2022. Compared with beneficiaries in TM, MA enrollees were more likely to be from socially vulnerable areas, have more comorbidities, and undergo surgery at nonteaching hospitals across all cancer types. Compared with those in TM, MA beneficiaries were less likely to undergo surgery at a high-quality hospital. For example, 21.7% (95% CI, 20.7%-22.8%) of patients enrolled in TA had an esophagectomy at a high-quality hospital vs 17.3% (95% CI, 16.1%-18.5%) of MA beneficiaries, and 22.6% (95% CI, 22.1%-23.2%) of patients enrolled in TA had a pancreatectomy at a high-quality hospital vs 16.2% (95% CI, 15.6%-16.8%) of those in MA. TM beneficiaries were more likely to bypass a lower-quality hospital to receive surgery at a high-quality hospital for all procedures. CONCLUSIONS AND RELEVANCE: This study found that MA enrollees were less likely to receive cancer surgery at high-quality hospitals and less likely to bypass lower-quality hospitals. These findings suggest that current MA plan networks may limit access to optimal surgical care, raising concerns about the adequacy of cancer care delivery under privatized Medicare.
引用
- Maganty A, Liu X, Dall C, et al. Surgery at High-Quality Hospitals Among Medicare Advantage Beneficiaries Undergoing Cancer Surgery. JAMA Surg. 2025. PMID: 41091515. doi:10.1001/jamasurg.2025.4320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。